GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » Other Stockholders Equity

HALB (Halberd) Other Stockholders Equity : $0.00 Mil (As of Jul. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Halberd Other Stockholders Equity?

Halberd's Other Stockholders Equity for the quarter that ended in Jul. 2023 was $0.00 Mil.

Halberd's quarterly Other Stockholders Equity increased from Jul. 2008 ($0.00 Mil) to Jul. 2022 ($0.00 Mil) but then declined from Jul. 2022 ($0.00 Mil) to Jul. 2023 ($0.00 Mil).

Halberd's annual Other Stockholders Equity increased from Jul. 2008 ($0.00 Mil) to Jul. 2022 ($0.00 Mil) but then declined from Jul. 2022 ($0.00 Mil) to Jul. 2023 ($0.00 Mil).


Halberd Other Stockholders Equity Historical Data

The historical data trend for Halberd's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd Other Stockholders Equity Chart

Halberd Annual Data
Trend Jul08 Jul22 Jul23
Other Stockholders Equity
- - -

Halberd Semi-Annual Data
Jul08 Jul22 Jul23
Other Stockholders Equity - - -

Halberd Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Halberd Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Halberd's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Halberd Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box 25, Jackson Center, PA, USA, 16133
Halberd Corp is a holding company and acquisition vehicle for established businesses. It is also developing a patented process for disease eradication by removing the pathophysiologic basis of the disease. The company is focused on developing treatments for neurodegenerative diseases, such as PTSD and CTE (Post Traumatic Stress Disorder and Chronic Traumatic Encephalopathy), Alzheimer's Disease, Parkinson's Disease, etc.
Executives
John Christopher Maddox director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO 10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist director, 10 percent owner, officer: CEO, Secretary and Director 24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr. director 50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas director 280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236